AnovaOS Network Powered Patient Registry

Launched by ANOVA ENTERPRISES, INC · Aug 18, 2021

Keywords

ClinConnect Summary

The AnovaOS Network Powered Patient Registry is a clinical trial designed to gather important information about patients with various complex diseases, including infections, cancers, blood disorders, and many other health issues. The goal is to create a registry that collects real-world data on how these diseases are diagnosed, treated, and the outcomes for patients around the world. This information will help improve understanding and treatment of these conditions.

To participate in this study, individuals must be at least 18 years old and have a confirmed diagnosis of a disease or condition, which can be reported by themselves or their healthcare provider. Participants should be willing to complete some questions about their health and agree to follow up once a year. Importantly, they also need to understand the study and be able to give their consent to join. This trial is currently seeking participants of all genders, so if you or someone you know fits the criteria, this could be an opportunity to contribute valuable information that may help improve healthcare for others.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years old or older;
• • Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
• • Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
• • Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
• • Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
• • Anticipated additional follow up with the registry once per year.
• Exclusion Criteria:
• • Subjects who do not meet the inclusion criteria for the study;
• • Subjects who are unable to understand the protocol or unable to provide legally effective informed consent